Assignee
MOMENTA PHARMACEUTICALS INC
US·83 granted patents·96 pending applications·672 citations·filing 2003–2025
Top patents by PatentIndex Score
179 records- 0198US10144944B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Dec 4, 2018·42 cites·23 claims
- 0298US9663810B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·57 cites·24 claims
- 0397US9926583B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Mar 27, 2018·42 cites·36 claims
- 0497US9217168B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Dec 22, 2015·68 cites·28 claims
- 0597US8956830B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Feb 17, 2015·58 cites·57 claims
- 0696US9487810B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2014·Granted Nov 8, 2016·48 cites·69 claims
- 0796US8852889B2Cell culture processMOMENTA PHARMACEUTICALS INC·Filed 2014·Granted Oct 7, 2014·22 cites·30 claims
- 0895US8703498B2Multi-dimensional chromatographic methods for separating N-glycansMOMENTA PHARMACEUTICALS INC·Filed 2012·Granted Apr 22, 2014·19 cites·28 claims
- 0994US10676526B2FcRn antibodies and methods of use thereofMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Jun 9, 2020·9 cites·19 claims
- 1094US7884187B2Analysis of amino acid copolymer compositionsMOMENTA PHARMACEUTICALS INC·Filed 2010·Granted Feb 8, 2011·15 cites·14 claims
- 1193US7575886B2Analysis of sulfated polysaccharidesMOMENTA PHARMACEUTICALS INC·Filed 2003·Granted Aug 18, 2009·68 cites·69 claims
- 1292US11623964B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Apr 11, 2023·6 cites·7 claims
- 1392US11220531B2Engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2018·Granted Jan 11, 2022·6 cites·5 claims
- 1492US11155640B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Oct 26, 2021·6 cites·2 claims
- 1592US11124573B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2019·Granted Sep 21, 2021·6 cites·40 claims
- 1692US10239944B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Mar 26, 2019·13 cites·24 claims
- 1791US7790466B1Evaluating mixtures of low molecular weight heparins by chain profiles or chain mappingMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Sep 7, 2010·15 cites·8 claims
- 1890US12360119B2Methods related to biologicsMOMENTA PHARMACEUTICALS INC·Filed 2023·Granted Jul 15, 2025·1 cites·14 claims
- 1990US8592142B2Analysis of amino acid copolymer compositionsMOMENTA PHARMACEUTICALS INC·Filed 2012·Granted Nov 26, 2013·5 cites·19 claims
- 2090US2025115940A1Cell culture processMOMENTA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2189US11352415B2Methods for the treatment of neurodegenerationMOMENTA PHARMACEUTICALS INC·Filed 2019·Granted Jun 7, 2022·4 cites·5 claims
- 2289US9890410B2N-acetylhexosamine-containing N-glycans in glycoprotein productsMOMENTA PHARMACEUTICALS INC·Filed 2015·Granted Feb 13, 2018·7 cites·34 claims
- 2388US9677105B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Jun 13, 2017·7 cites·24 claims
- 2488US8361705B2Characterization of N-glycans using exoglycosidasesMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Jan 29, 2013·14 cites·13 claims
- 2588US7816144B1Evaluating mixtures of low molecular weight heparins by chain profiles or chain mappingMOMENTA PHARMACEUTICALS INC·Filed 2009·Granted Oct 19, 2010·10 cites·7 claims
- 2687US11345751B2FcRn antibodies and methods of use thereofMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted May 31, 2022·4 cites·40 claims
- 2787US8921116B2Methods of evaluating diethylamide in peptide mixtures for the preparation of glatiramer acetateMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Dec 30, 2014·5 cites·7 claims
- 2886US11661456B2Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2018·Granted May 30, 2023·4 cites·4 claims
- 2985US11719704B2Methods related to biologicsMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Aug 8, 2023·3 cites·15 claims
- 3085US10464996B2Methods for the treatment of neurodegenerationMOMENTA PHARMACEUTICALS INC·Filed 2014·Granted Nov 5, 2019·7 cites·6 claims
- 3185US9663581B2Modified glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted May 30, 2017·7 cites·15 claims
- 3285US2024141401A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3385US2024167069A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3484US7968082B1Evaluating mixtures of low molecular weight heparins by NMRMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Jun 28, 2011·24 cites·21 claims
- 3584US2025011432A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3684US2024279703A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3783US11732047B2FcRn antibodies and methods of use thereofMOMENTA PHARMACEUTICALS INC·Filed 2020·Granted Aug 22, 2023·1 cites·26 claims
- 3883US9085796B2Analysis of amino acid copolymer compositionsMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·4 cites·20 claims
- 3983US8043863B2MS methods to evaluate glycansMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·14 cites·20 claims
- 4083US7947507B2Analysis of sulfated polysaccharidesMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted May 24, 2011·4 cites·9 claims
- 4182US10584365B2Cell culture processMOMENTA PHARMACEUTICALS INC·Filed 2018·Granted Mar 10, 2020·1 cites·16 claims
- 4281US9448147B2Multi-dimensional chromatographic methods for separating N-glycansMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Sep 20, 2016·2 cites·20 claims
- 4381US7811827B2Methods and apparatus for characterizing heparin-like glycosaminoglycan mixturesMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Oct 12, 2010·8 cites·39 claims
- 4481US2024067757A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4579US12297256B2Methods for the treatment of neurodegenerationMOMENTA PHARMACEUTICALS INC·Filed 2022·Granted May 13, 2025·0 cites·16 claims
- 4679US2024209040A1ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4778US12163951B2Methods for predicting response to treatmentMOMENTA PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·0 cites·10 claims
- 4878US9933432B2Multi-dimensional chromatographic methods for separating N-glycansMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·1 cites·22 claims
- 4978US2024158508A1FcRn Antibodies and Methods of Use ThereofMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 5077US7767420B2Heparan sulfate glycosaminoglycan lyase and uses thereofMOMENTA PHARMACEUTICALS INC·Filed 2005·Granted Aug 3, 2010·2 cites·9 claims
Showing the top 50 of 179 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →